Clinical Trials Logo
  1. Home
  2. Pilomatrixoma
  3. NCT00715819
  4. Details
NCT00715819 Clinical Trial

Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma

Pilomatrixoma Clinical Trial

Official title:
Use of Otoscope as a Non-Invasive Tool for Diagnosis of Pilomatricoma

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT00715819
Other study ID # SU-07092008-1245
Secondary ID eProtocol #:1321
Status Recruiting
Phase N/A
First received July 11, 2008
Last updated February 17, 2009
Start date April 2008

Study information
Verified date February 2009
Source Stanford University
Contact Emily S Gorell
Phone (650) 721-7159
Email egorell@stanford.edu
Is FDA regulated No
Health authority United States: Food and Drug Administration
Study type Observational

Clinical Trial Summary

Stanford University Dermatology Clinics and Lucile Packard Children's Hospital are evaluating the use of the otoscope for the diagnosis of skin lesions. We are particularly looking for children and/or adults with nodules, cysts, tumors, or pilomatricomas. The study will take 15-30 minutes and we will use light to examine and take a picture of your skin lesion. There is no monetary compensation for participating in the study.

Description:

Pilomatricoma is a benign tumor that presents as a 3-30mm firm, solitary, deep dermal or subcutaneous tumor on the head, neck, or upper extremities. The clinical diagnosis is often made by the firm, sometimes rock hard texture of the skin. The diagnosis can be confirmed by a skin biopsy and/or excision of the lesion. We have recently noted that pilomatricomas appear as a black mass in the skin when the lesion is transilluminated by placing the light of a fiberoptic otoscope adjacent to the skin lesion. We would like to confirm our impression by a prospective study using transillumination to examine subcutaneous tumors in the skin. Pilomatricoma is also known as a benign calcifying or calcified epithelioma, pilomatrixoma, or a calcifying epithelioma of Malherbe.

Recruitment information / eligibility
Status Recruiting
Enrollment 30
Est. completion date
Est. primary completion date December 2009
Accepts healthy volunteers No
Gender Both
Age group N/A and older
Eligibility Inclusion Criteria:- Potential participants will be any patient that is seen at Stanford Dermatology or LPCH that has a cyst, nodule, vesicle, tumor, or possible pilomatricoma

Exclusion Criteria:- Inability of subject or subject's guardian to understand informed consent form.

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

Locations
Country Name City State
United States Stanford University School of Medicine Stanford California

Sponsors (1)
Lead Sponsor Collaborator
Stanford University

Country where clinical trial is conducted

United States,